Sean Christensen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sean christensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sean Christensen Today - Breaking & Trending Today

DexCom (DXCM) Q1 2024 Earnings Call Transcript

DXCM earnings call for the period ending March 31, 2024. ....

United States , United Kingdom , Matt Miksic Barclays , Danielle Antalffy , Steve Lichtman Oppenheimer , Shagun Singh , Steve Lichtman , Matt Miksic , Margaret Andrew , Larry Biegelsen , Mike Kratky Leerink , Jereme Sylvain , Joanne Wuensch , Jayson Bedford Raymond James , Kevin Sayer , Joanne Wuensch Citi , Sean Christensen , Matt Taylor , Michael Polark , Jeff Johnson Baird , Piper Sandler , Plovanic Canaccord Genuity , William Blair , Josh Jennings , Canaccord Genuity , Mike Kratky ,

Transplant Recipients: Consider Skin Cancer, Infection Risks

Recent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients. ....

United States , New Haven , Yale University , Sean Christensen , American Academy Of Dermatology , Gel Technologies Ltd , Canfield Scientific Inc , American Academy , Transplant Risk Assessment Calculator , Canfield Scientific , Inhibitor Therapeutics , Sol Gel Technologies ,

Dexcom Announces Upcoming Conference Presentation

DexCom, Inc. today announced that Sean Christensen, Vice President, Finance and Investor Relations, will present an update on the company at the 45th Annual Raymond James Institutional Investors. ....

San Diego , United States , Sean Christensen , Dexcom Inc , Vice President , Investor Relations , Dexcom Investor Relations ,

Dexcom Announces Upcoming Conference Presentation

SAN DIEGO (BUSINESS WIRE) DexCom, Inc. (NASDAQ:DXCM) today announced ....

Sean Christensen , Dexcom Inc , Vice President , Investor Relations ,

Tools on the Horizon for Managing Posttransplant cSCC Risk

Organ transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients. ....

Yale University , United States , San Francisco , Johns Hopkins , Sean Christensen , Matthew Bottomley , Sarah Arron , Drug Administration , University Of Oxford , Journal Of The American Academy Dermatology , Centers For Disease , Yale Dermatology , Transplant International , End Results , Disease Control , Kristin Page Bibee , Oxford Kidney , Transplant Unit , High Risk Skin Cancer Program , Ultraviolet Neoplasia Transplant Risk Assessment , Delphi Consensus Statement , American Academy , New England Journal , Skin Cancer , Alignant Skin Neoplasm , Biologic Therapy ,